OTCMKTS:BCYP

Big Cypress Acquisition - BCYP Stock Forecast, Price & News

$8.44

-2.01 (-19.23%)

(As of 10/22/2021)

Add

Compare

Today's Range: $8.21
▼
$12.90
50-Day Range: $8.44
▼
$8.44
52-Week Range: $8.21
▼
$12.90

Volume: 15.34 million shs
Average Volume: 160,982 shs
Market Capitalization: $124.84 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $17.25

About Big Cypress Acquisition (OTCMKTS:BCYP) Stock

Big Cypress Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It primarily focuses in the life science sector. The company was incorporated in 2020 and is based in Miami Beach, Florida.

Receive BCYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCYP Stock News Headlines

March 2, 2022 | reuters.com

SAB Biotherapeutics Inc

October 21, 2021 | finance.yahoo.com

Big Cypress Acquisition Corp. Stockholders Approve Business Combination with SAB Biotherapeutics

October 4, 2021 | finance.yahoo.com

SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19

September 28, 2021 | finance.yahoo.com

SAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer

September 24, 2021 | finance.yahoo.com

SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19

September 22, 2021 | finance.yahoo.com

SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19

September 15, 2021 | finance.yahoo.com

SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza

September 8, 2021 | finance.yahoo.com

SAB Biotherapeutics to Present at Upcoming September Virtual Investor Conferences

August 11, 2021 | barrons.com

Big Cypress Acquisition Corp.

August 11, 2021 | finance.yahoo.com

SAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants

August 10, 2021 | nasdaq.com

Big Cypress Acquisition Corp. Common stock (BCYP)

July 15, 2021 | in.finance.yahoo.com

STMP Jul 2021 300.000 put

July 15, 2021 | finance.yahoo.com

Big Cypress Acquisition Corp. Reports Ladenburg Conference Presentation by Planned Merger Partner SAB Biotherapeutics

July 10, 2021 | finance.yahoo.com

Lifshitz Law Firm, P.C. Announces Investigation of ALTA, BCYP, IKNX and STMP

July 7, 2021 | finance.yahoo.com

Big Cypress Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination with SAB Biotherapeutics

June 28, 2021 | finance.yahoo.com

NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: CITIC Capital Acquisition Corp. (NYSE - CCAC), Thimble Point Acquisition Corp. (Nasdaq - THMA), Big Cypress Acquisition Corp. (Nasdaq - BCYP)

June 25, 2021 | feeds.benzinga.com

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Big Cypress Acquisition Corp. Merger

June 22, 2021 | finance.yahoo.com

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Big Cypress Acquisition Corp. (Nasdaq - BCYP)

June 22, 2021 | finance.yahoo.com

SAB Biotherapeutics to List on Nasdaq through Merger with Big Cypress Acquisition Corp., Advancing Unique Human Antibody Platform with Demonstrated Utility in Immunotherapy and Rapid Response to Emerging Diseases

April 26, 2021 | msn.com

Inside Primary Wave’s $1.5 Billion Hit Factory

April 21, 2021 | msn.com

'It was beautiful': Rancho Bonito's neighbors say action is needed to protect environment

April 2, 2021 | bizjournals.com

Real Estate Deals: 6x6 deal gives mid-Market a taste of Sweden

March 12, 2021 | seekingalpha.com

HCI Group's (HCI) CEO Paresh Patel on Q4 2020 Results - Earnings Call Transcript

March 12, 2021 | msn.com

HCI Group Inc (HCI) Q4 2020 Earnings Call Transcript

March 1, 2021 | msn.com

Xenia Hotels and Resorts (XHR) Q4 2020 Earnings Call Transcript

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BCYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCYP Company Calendar

Last Earnings: 11/11/2014
Today: 9/27/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:BCYP
CUSIP: N/A
CIK: 1399587
Web: www.bluecalypso.com
Phone: 305-204-3338
Fax: N/A
Employees: 5
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $17.25
High Stock Price Forecast: $18.00
Low Stock Price Forecast: $16.50
Forecasted Upside/Downside: +104.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.13
Quick Ratio: 6.13

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 14,792,000
Free Float: N/A
Market Cap: $124.84 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Samuel J. Reich (Age 46)
CEO, CFO & Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BCYP Stock - Frequently Asked Questions

Should I buy or sell Big Cypress Acquisition stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Big Cypress Acquisition in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BCYP shares.
View BCYP analyst ratings or view top-rated stocks.
What is Big Cypress Acquisition's stock price forecast for 2022?: 2 Wall Street research analysts have issued twelve-month price targets for Big Cypress Acquisition's stock. Their BCYP share price forecasts range from $16.50 to $18.00. On average, they expect the company's stock price to reach $17.25 in the next year. This suggests a possible upside of 104.4% from the stock's current price.
View analysts price targets for BCYP or view top-rated stocks among Wall Street analysts.
How have BCYP shares performed in 2022?: Big Cypress Acquisition's stock was trading at $8.44 at the beginning of 2022. Since then, BCYP stock has increased by 0.0% and is now trading at $8.44.
View the best growth stocks for 2022 here.
How were Big Cypress Acquisition's earnings last quarter?: Big Cypress Acquisition Corp. (OTCMKTS:BCYP) posted its earnings results on Tuesday, November, 11th. The technology company reported ($0.01) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to the consensus estimate of $0.21 million.

What other stocks do shareholders of Big Cypress Acquisition own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Big Cypress Acquisition investors own include Co-Diagnostics (CODX), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).
What is Big Cypress Acquisition's stock symbol?: Big Cypress Acquisition trades on the OTCMKTS under the ticker symbol "BCYP."
How do I buy shares of Big Cypress Acquisition?: Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Big Cypress Acquisition's stock price today?: One share of BCYP stock can currently be purchased for approximately $8.44.
How much money does Big Cypress Acquisition make?: Big Cypress Acquisition (OTCMKTS:BCYP) has a market capitalization of $124.84 million.
How can I contact Big Cypress Acquisition?: Big Cypress Acquisition's mailing address is 101 W. RENNER RD., RICHARDSON TX, 75082. The official website for the company is www.bluecalypso.com. The technology company can be reached via phone at 305-204-3338 or via email at investors@bluecalypso.com.

This page (OTCMKTS:BCYP) was last updated on 9/27/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial